Psychopathological comorbidities in medication-overuse headache: a multicentre clinical study

Background and purpose In medication‐overuse headache (MOH) patients, the presence of psychopathological disturbances may be a predictor of relapse and poor response to treatment. This multicentre study aimed to assess the occurrence of psychopathological disorders in MOH patients by comparing the i...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of neurology Vol. 23; no. 1; pp. 85 - 91
Main Authors Sarchielli, P., Corbelli, I., Messina, P., Cupini, L. M., Bernardi, G., Bono, G., Di Piero, V., Petolicchio, B., Livrea, P., Prudenzano, M. P., Pini, L. A., Sandrini, G., Allena, M., Tedeschi, G., Russo, A., Caproni, S., Beghi, E., Calabresi, P.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.01.2016
Subjects
Adult
case-control studies
Comorbidity
Female
headache
Headache Disorders, Secondary - epidemiology
Humans
Male
medication-overuse headache
Mental Disorders - epidemiology
Middle Aged
migraine
Migraine Disorders - epidemiology
obsessive−compulsive disturbances
Prevalence
psychiatric disorders
migraine
headache
obsessive−compulsive disturbances
medication-overuse headache
case-control studies
psychiatric disorders
Online AccessGet full text

Cover

Abstract Background and purpose In medication‐overuse headache (MOH) patients, the presence of psychopathological disturbances may be a predictor of relapse and poor response to treatment. This multicentre study aimed to assess the occurrence of psychopathological disorders in MOH patients by comparing the incidence of psychopathological disturbances with episodic migraine (EM) patients and healthy controls (HC). Methods The psychopathological assessment of patients and HC involved the administrations of the Beck Depression Inventory, the Beck Anxiety Inventory, the Modified Mini International Neuropsychiatric Interview (M‐MINI), the Yale−Brown Obsessive Compulsive Scale (Y‐BOCS) and the Leeds Dependence Questionnaire. Results The MOH, EM and HC groups (88, 129 and 102 subjects, respectively) differed significantly from each other for the presence of moderate/severe anxiety, whereas mood disorder and depression were revealed in similar proportions for both MOH and EM patients. By stratifying the M‐MINI questionnaire results according to the number of psychiatric disorders, it was found that MOH patients had a more complex profile of psychiatric comorbidity. Furthermore, clinically relevant obsessive−compulsive disturbances for abused drugs assessed by Y‐BOCS appeared to be more represented in the MOH group, whilst the prevalence of this trait in the EM group was comparable to that of HC (12.5%, 0.8% and 0%, respectively). Conclusions Our study indicates the multiple presence of psychopathological comorbidities in patients with MOH. In light of this, it is recommended that the assessment of the psychopathological profile be included in an evaluation of MOH patients, allowing the clinician to more rapidly start an appropriate behavioural treatment, which would greatly improve MOH management.
AbstractList In medication-overuse headache (MOH) patients, the presence of psychopathological disturbances may be a predictor of relapse and poor response to treatment. This multicentre study aimed to assess the occurrence of psychopathological disorders in MOH patients by comparing the incidence of psychopathological disturbances with episodic migraine (EM) patients and healthy controls (HC). The psychopathological assessment of patients and HC involved the administrations of the Beck Depression Inventory, the Beck Anxiety Inventory, the Modified Mini International Neuropsychiatric Interview (M-MINI), the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and the Leeds Dependence Questionnaire. The MOH, EM and HC groups (88, 129 and 102 subjects, respectively) differed significantly from each other for the presence of moderate/severe anxiety, whereas mood disorder and depression were revealed in similar proportions for both MOH and EM patients. By stratifying the M-MINI questionnaire results according to the number of psychiatric disorders, it was found that MOH patients had a more complex profile of psychiatric comorbidity. Furthermore, clinically relevant obsessive-compulsive disturbances for abused drugs assessed by Y-BOCS appeared to be more represented in the MOH group, whilst the prevalence of this trait in the EM group was comparable to that of HC (12.5%, 0.8% and 0%, respectively). Our study indicates the multiple presence of psychopathological comorbidities in patients with MOH. In light of this, it is recommended that the assessment of the psychopathological profile be included in an evaluation of MOH patients, allowing the clinician to more rapidly start an appropriate behavioural treatment, which would greatly improve MOH management.
Background and purpose In medication‐overuse headache (MOH) patients, the presence of psychopathological disturbances may be a predictor of relapse and poor response to treatment. This multicentre study aimed to assess the occurrence of psychopathological disorders in MOH patients by comparing the incidence of psychopathological disturbances with episodic migraine (EM) patients and healthy controls (HC). Methods The psychopathological assessment of patients and HC involved the administrations of the Beck Depression Inventory, the Beck Anxiety Inventory, the Modified Mini International Neuropsychiatric Interview (M‐MINI), the Yale−Brown Obsessive Compulsive Scale (Y‐BOCS) and the Leeds Dependence Questionnaire. Results The MOH, EM and HC groups (88, 129 and 102 subjects, respectively) differed significantly from each other for the presence of moderate/severe anxiety, whereas mood disorder and depression were revealed in similar proportions for both MOH and EM patients. By stratifying the M‐MINI questionnaire results according to the number of psychiatric disorders, it was found that MOH patients had a more complex profile of psychiatric comorbidity. Furthermore, clinically relevant obsessive−compulsive disturbances for abused drugs assessed by Y‐BOCS appeared to be more represented in the MOH group, whilst the prevalence of this trait in the EM group was comparable to that of HC (12.5%, 0.8% and 0%, respectively). Conclusions Our study indicates the multiple presence of psychopathological comorbidities in patients with MOH. In light of this, it is recommended that the assessment of the psychopathological profile be included in an evaluation of MOH patients, allowing the clinician to more rapidly start an appropriate behavioural treatment, which would greatly improve MOH management.
Background and purpose In medication-overuse headache (MOH) patients, the presence of psychopathological disturbances may be a predictor of relapse and poor response to treatment. This multicentre study aimed to assess the occurrence of psychopathological disorders in MOH patients by comparing the incidence of psychopathological disturbances with episodic migraine (EM) patients and healthy controls (HC). Methods The psychopathological assessment of patients and HC involved the administrations of the Beck Depression Inventory, the Beck Anxiety Inventory, the Modified Mini International Neuropsychiatric Interview (M-MINI), the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and the Leeds Dependence Questionnaire. Results The MOH, EM and HC groups (88, 129 and 102 subjects, respectively) differed significantly from each other for the presence of moderate/severe anxiety, whereas mood disorder and depression were revealed in similar proportions for both MOH and EM patients. By stratifying the M-MINI questionnaire results according to the number of psychiatric disorders, it was found that MOH patients had a more complex profile of psychiatric comorbidity. Furthermore, clinically relevant obsessive-compulsive disturbances for abused drugs assessed by Y-BOCS appeared to be more represented in the MOH group, whilst the prevalence of this trait in the EM group was comparable to that of HC (12.5%, 0.8% and 0%, respectively). Conclusions Our study indicates the multiple presence of psychopathological comorbidities in patients with MOH. In light of this, it is recommended that the assessment of the psychopathological profile be included in an evaluation of MOH patients, allowing the clinician to more rapidly start an appropriate behavioural treatment, which would greatly improve MOH management.
In medication-overuse headache (MOH) patients, the presence of psychopathological disturbances may be a predictor of relapse and poor response to treatment. This multicentre study aimed to assess the occurrence of psychopathological disorders in MOH patients by comparing the incidence of psychopathological disturbances with episodic migraine (EM) patients and healthy controls (HC).BACKGROUND AND PURPOSEIn medication-overuse headache (MOH) patients, the presence of psychopathological disturbances may be a predictor of relapse and poor response to treatment. This multicentre study aimed to assess the occurrence of psychopathological disorders in MOH patients by comparing the incidence of psychopathological disturbances with episodic migraine (EM) patients and healthy controls (HC).The psychopathological assessment of patients and HC involved the administrations of the Beck Depression Inventory, the Beck Anxiety Inventory, the Modified Mini International Neuropsychiatric Interview (M-MINI), the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and the Leeds Dependence Questionnaire.METHODSThe psychopathological assessment of patients and HC involved the administrations of the Beck Depression Inventory, the Beck Anxiety Inventory, the Modified Mini International Neuropsychiatric Interview (M-MINI), the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and the Leeds Dependence Questionnaire.The MOH, EM and HC groups (88, 129 and 102 subjects, respectively) differed significantly from each other for the presence of moderate/severe anxiety, whereas mood disorder and depression were revealed in similar proportions for both MOH and EM patients. By stratifying the M-MINI questionnaire results according to the number of psychiatric disorders, it was found that MOH patients had a more complex profile of psychiatric comorbidity. Furthermore, clinically relevant obsessive-compulsive disturbances for abused drugs assessed by Y-BOCS appeared to be more represented in the MOH group, whilst the prevalence of this trait in the EM group was comparable to that of HC (12.5%, 0.8% and 0%, respectively).RESULTSThe MOH, EM and HC groups (88, 129 and 102 subjects, respectively) differed significantly from each other for the presence of moderate/severe anxiety, whereas mood disorder and depression were revealed in similar proportions for both MOH and EM patients. By stratifying the M-MINI questionnaire results according to the number of psychiatric disorders, it was found that MOH patients had a more complex profile of psychiatric comorbidity. Furthermore, clinically relevant obsessive-compulsive disturbances for abused drugs assessed by Y-BOCS appeared to be more represented in the MOH group, whilst the prevalence of this trait in the EM group was comparable to that of HC (12.5%, 0.8% and 0%, respectively).Our study indicates the multiple presence of psychopathological comorbidities in patients with MOH. In light of this, it is recommended that the assessment of the psychopathological profile be included in an evaluation of MOH patients, allowing the clinician to more rapidly start an appropriate behavioural treatment, which would greatly improve MOH management.CONCLUSIONSOur study indicates the multiple presence of psychopathological comorbidities in patients with MOH. In light of this, it is recommended that the assessment of the psychopathological profile be included in an evaluation of MOH patients, allowing the clinician to more rapidly start an appropriate behavioural treatment, which would greatly improve MOH management.
Author Messina, P.
Di Piero, V.
Petolicchio, B.
Russo, A.
Tedeschi, G.
Bernardi, G.
Bono, G.
Pini, L. A.
Prudenzano, M. P.
Livrea, P.
Caproni, S.
Beghi, E.
Corbelli, I.
Allena, M.
Sarchielli, P.
Cupini, L. M.
Calabresi, P.
Sandrini, G.
Author_xml – sequence: 1
  givenname: P.
  surname: Sarchielli
  fullname: Sarchielli, P.
  email: paola.sarchielli@gmail.com
  organization: Clinica Neurologica, Azienda Ospedaliero − Universitaria di Perugia, Perugia, Italy
– sequence: 2
  givenname: I.
  surname: Corbelli
  fullname: Corbelli, I.
  organization: Clinica Neurologica, Azienda Ospedaliero − Universitaria di Perugia, Perugia, Italy
– sequence: 3
  givenname: P.
  surname: Messina
  fullname: Messina, P.
  organization: IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy
– sequence: 4
  givenname: L. M.
  surname: Cupini
  fullname: Cupini, L. M.
  organization: Centro Cefalee e Malattie Cerebrovascolari, Ospedale S. Eugenio, Rome, Italy
– sequence: 5
  givenname: G.
  surname: Bernardi
  fullname: Bernardi, G.
  organization: Clinica Neurologica, Policlinico TorVergata, Rome, Italy
– sequence: 6
  givenname: G.
  surname: Bono
  fullname: Bono, G.
  organization: UCADH-Varese, Department Biotechnology and Life Sciences University of Insubria-Varese, Varese, Italy
– sequence: 7
  givenname: V.
  surname: Di Piero
  fullname: Di Piero, V.
  organization: Dipartimento di Neurologia e Psichiatria, 'Sapienza' Università di Roma, Rome, Italy
– sequence: 8
  givenname: B.
  surname: Petolicchio
  fullname: Petolicchio, B.
  organization: Dipartimento di Neurologia e Psichiatria, 'Sapienza' Università di Roma, Rome, Italy
– sequence: 9
  givenname: P.
  surname: Livrea
  fullname: Livrea, P.
  organization: Clinica Neurologica, Policlinico di Bari, Bari, Italy
– sequence: 10
  givenname: M. P.
  surname: Prudenzano
  fullname: Prudenzano, M. P.
  organization: Clinica Neurologica, Policlinico di Bari, Bari, Italy
– sequence: 11
  givenname: L. A.
  surname: Pini
  fullname: Pini, L. A.
  organization: Centro Cefalee, Università degli Studi di Modena e Reggio Emilia, Modena, Italy
– sequence: 12
  givenname: G.
  surname: Sandrini
  fullname: Sandrini, G.
  organization: Department of Brain and Behavioural Sciences, C. Mondino National Neurological Institute, University of Pavia, Pavia, Italy
– sequence: 13
  givenname: M.
  surname: Allena
  fullname: Allena, M.
  organization: Department of Brain and Behavioural Sciences, C. Mondino National Neurological Institute, University of Pavia, Pavia, Italy
– sequence: 14
  givenname: G.
  surname: Tedeschi
  fullname: Tedeschi, G.
  organization: Clinica Neurologica, II Università degli Studi di Napoli, Napoli, Italy
– sequence: 15
  givenname: A.
  surname: Russo
  fullname: Russo, A.
  organization: Clinica Neurologica, II Università degli Studi di Napoli, Napoli, Italy
– sequence: 16
  givenname: S.
  surname: Caproni
  fullname: Caproni, S.
  organization: Clinica Neurologica, Azienda Ospedaliero − Universitaria di Perugia, Perugia, Italy
– sequence: 17
  givenname: E.
  surname: Beghi
  fullname: Beghi, E.
  organization: IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy
– sequence: 18
  givenname: P.
  surname: Calabresi
  fullname: Calabresi, P.
  organization: Clinica Neurologica, Azienda Ospedaliero − Universitaria di Perugia, Perugia, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26228376$$D View this record in MEDLINE/PubMed
BookMark eNqNkcFP2zAYxS0EGpTtwD-AcoRDqO04ccINVR3bVLpNAvWELMf5sno4cbGdQf_7mRY4TALNPviTv997h_dGaLe3PSB0RPAZiWcMPZwRyiu2gw4IK8qUZBnZjXOWkzQnmOyjkfe_McaUU_wB7dOC0jLjxQG6_eHXamlXMiytsb-0kiZRtrOu1o0OGnyi-6SDJi6Ctn1q_4AbPCRLkI1USzhPZNINJmgFfXCQKKP7jYkPQ7P-iPZaaTx8en4P0c3n6fXkSzr7fvl1cjFLFcsISytKSsxaqHnJKsqgatv4Xzcql6wGyfOylixu48VVRaGkVUsBaMty3DJGs0N0svVdOXs_gA-i016BMbIHO3hBOC-KnDNS_gda4DKvOH9yPX5GhzpGIFZOd9KtxUt6ETjdAspZ7x20rwjB4qkZEZsRm2YiO_6HVTpsMg1OavOe4kEbWL9tLabz6Ysi3Sq0D_D4qpDuThQ847lYzC_FhP9cfOPzhbjK_gIHda7Z
CitedBy_id crossref_primary_10_1007_s10072_018_3390_6
crossref_primary_10_3389_fpain_2023_1103497
crossref_primary_10_1177_25158163251318713
crossref_primary_10_1186_s10194_024_01766_7
crossref_primary_10_1007_s11916_019_0796_7
crossref_primary_10_1186_s10194_018_0884_9
crossref_primary_10_15388_NS_2024_28_99_5
crossref_primary_10_1111_ene_13674
crossref_primary_10_1007_s10072_017_3054_y
crossref_primary_10_3390_toxins11090504
crossref_primary_10_3390_life14091146
crossref_primary_10_1186_s10194_019_0988_x
crossref_primary_10_3390_brainsci13101408
crossref_primary_10_1111_head_14732
crossref_primary_10_1038_nrneurol_2016_124
crossref_primary_10_1111_ene_13480
crossref_primary_10_1111_head_13785
crossref_primary_10_1111_head_14056
crossref_primary_10_3389_fpain_2023_1194134
crossref_primary_10_1097_j_pain_0000000000001291
crossref_primary_10_1016_j_jpsychores_2018_12_001
crossref_primary_10_1186_s42466_022_00200_0
crossref_primary_10_1016_j_nicl_2016_05_007
crossref_primary_10_1186_s10194_025_01988_3
crossref_primary_10_4103_ajim_ajim_77_20
crossref_primary_10_1186_s10194_018_0875_x
crossref_primary_10_1186_s12868_016_0326_z
crossref_primary_10_1016_j_therap_2024_02_001
crossref_primary_10_1038_s41572_022_00415_0
crossref_primary_10_1007_s40261_025_01433_y
crossref_primary_10_1080_00207454_2016_1196687
crossref_primary_10_3390_toxins12090577
crossref_primary_10_14412_2074_2711_2024_1S_12_18
crossref_primary_10_3389_fnhum_2020_571035
crossref_primary_10_1155_2019_1874078
crossref_primary_10_1007_s42451_022_00443_w
Cites_doi 10.1111/j.1526-4610.2010.01755.x
10.1016/S0924-9338(97)86748-X
10.1111/j.1526-4610.2007.00999.x
10.1007/s10194-012-0492-z
10.1159/000066239
10.1016/j.tips.2004.12.008
10.1177/0333102413485658
10.1212/WNL.56.3.350
10.1212/01.WNL.0000058907.41080.54
10.1111/j.1526-4610.2007.00970.x
10.1111/j.1360-0443.1994.tb03332.x
10.1111/j.1468-2982.2005.00910.x
10.1111/j.1526-4610.2005.05101.x
10.1007/s00415-012-6725-x
10.1111/j.1468-2982.2008.01555.x
10.1007/s11916-001-0070-6
10.1177/0333102410381145
10.1001/archpsyc.1990.01810210057008
10.1136/jnnp.2009.192492
10.1212/01.WNL.0000113747.18760.D2
10.1111/j.1468-2982.2004.00839.x
10.1111/j.1468-2982.2005.01020.x
10.1016/S0072-9752(10)97018-8
10.1212/WNL.55.5.629
10.1111/j.1526-4610.2009.01457.x
10.1016/j.euroneuro.2014.03.010
10.1111/j.1526-4610.2009.01370.x
10.1212/01.WNL.0000120545.45443.93
10.1093/brain/awh691
10.1212/WNL.54.2.308
10.1001/archpsyc.1989.01810110048007
10.1007/s10194-012-0447-4
10.1007/s004060170047
10.1002/(SICI)1097-4679(199701)53:1<7::AID-JCLP2>3.0.CO;2-S
10.1111/j.1526-4610.2008.01217.x
ContentType Journal Article
Contributor Squitieri, Martina
Guerzoni, Simona
Tessitore, Alessandro
Vicenzini, Edoardo
Berlangeri, Mariangela
Zandrini, Cinzia
Contributor_xml – sequence: 1
  givenname: Mariangela
  surname: Berlangeri
  fullname: Berlangeri, Mariangela
– sequence: 2
  givenname: Simona
  surname: Guerzoni
  fullname: Guerzoni, Simona
– sequence: 3
  givenname: Martina
  surname: Squitieri
  fullname: Squitieri, Martina
– sequence: 4
  givenname: Alessandro
  surname: Tessitore
  fullname: Tessitore, Alessandro
– sequence: 5
  givenname: Edoardo
  surname: Vicenzini
  fullname: Vicenzini, Edoardo
– sequence: 6
  givenname: Cinzia
  surname: Zandrini
  fullname: Zandrini, Cinzia
Copyright 2015 EAN
2015 EAN.
Copyright_xml – notice: 2015 EAN
– notice: 2015 EAN.
CorporateAuthor the SAMOHA Study Group
SAMOHA Study Group
CorporateAuthor_xml – name: the SAMOHA Study Group
– name: SAMOHA Study Group
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TK
DOI 10.1111/ene.12794
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitleList MEDLINE

Neurosciences Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-1331
EndPage 91
ExternalDocumentID 26228376
10_1111_ene_12794
ENE12794
ark_67375_WNG_C7QWJ7NW_M
Genre article
Multicenter Study
Clinical Study
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Agenzia Italiana del Farmaco
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
169
1OB
1OC
24P
29G
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
7X7
8-0
8-1
8-3
8-4
8-5
8FI
8FJ
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIVO
ABJNI
ABPVW
ABUWG
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADPDF
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFGKR
AFKRA
AFPWT
AFRAH
AFZJQ
AHMBA
AIACR
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BENPR
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EMOBN
ESX
EX3
F00
F5P
FEDTE
FUBAC
FYBCS
FYUFA
G-S
G.N
GODZA
H.X
HF~
HMCUK
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
OVEED
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIG
RIWAO
RJQFR
ROL
RPM
RX1
SAMSI
SUPJJ
TEORI
UB1
UKHRP
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AANHP
AAYCA
ACCMX
ACRPL
ACYXJ
ADNMO
AFWVQ
AAYXX
AGQPQ
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TK
ID FETCH-LOGICAL-c4314-921804feb784924e9ff431bdc5a4bea758ba4eb7b7b0992e829f2ee2f450f4423
IEDL.DBID DR2
ISSN 1351-5101
1468-1331
IngestDate Thu Jul 10 19:22:31 EDT 2025
Fri Jul 11 16:32:40 EDT 2025
Mon Jul 21 06:01:59 EDT 2025
Thu Apr 24 23:05:17 EDT 2025
Tue Jul 01 02:47:41 EDT 2025
Wed Jan 22 16:24:29 EST 2025
Wed Oct 30 09:54:48 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords migraine
headache
obsessive−compulsive disturbances
medication-overuse headache
case-control studies
psychiatric disorders
Language English
License 2015 EAN.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4314-921804feb784924e9ff431bdc5a4bea758ba4eb7b7b0992e829f2ee2f450f4423
Notes Agenzia Italiana del Farmaco
ark:/67375/WNG-C7QWJ7NW-M
Table S1. Sex subgroup comparisons according to scales. Table S2. Age subgroup comparisons according to scales.
istex:E975AD845DCA1D7AB717D6120C9518B4F71D9CE8
ArticleID:ENE12794
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.12794
PMID 26228376
PQID 1760859772
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_1776657418
proquest_miscellaneous_1760859772
pubmed_primary_26228376
crossref_primary_10_1111_ene_12794
crossref_citationtrail_10_1111_ene_12794
wiley_primary_10_1111_ene_12794_ENE12794
istex_primary_ark_67375_WNG_C7QWJ7NW_M
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-01
January 2016
2016-01-00
2016-Jan
20160101
PublicationDateYYYYMMDD 2016-01-01
PublicationDate_xml – month: 01
  year: 2016
  text: 2016-01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle European journal of neurology
PublicationTitleAlternate Eur J Neurol
PublicationYear 2016
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References Raistrick D, Bradshaw J, Tober G, Weiner J, Allison J, Healey C. Development of the Leeds Dependence Questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package. Addiction 1994; 89: 563-572.
Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch Gen Psychiatry 1990; 47: 849-853.
Sarchielli P, Messina P, Cupini ML, et al. Sodium Valproate in Medication Overuse Headache Treatment: a placebo-controlled randomized trial. Eur Neuropsychopharmacol 2014; 24: 1289-1297.
Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008; 48: 1157-1168.
Breslau N, Schultz LR, Stewart WF, Lipton R, Welch KM. Headache types and panic disorder: directionality and specificity. Neurology 2001; 56: 350-354.
Buse DC, Silberstein SD, Manack AN, Papapetropoulos S, Lipton RB. Psychiatric comorbidities of episodic and chronic migraine. J Neurol 2013; 260: 1960-1969.
Radat F, Creac'h C, Guegan-Massardier E, et al. Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria. Headache 2008; 48: 1026-1036.
Ferrari A, Cicero AF, Bertolini A, Leone S, Pasciullo G, Sternieri E. Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ). Cephalalgia 2006; 26: 187-193.
Schulman EA, Peterlin BL, Lake AE III, et al. Defining refractory migraine: results of the RHSIS Survey of American Headache Society members. Headache 2009; 49: 509-518.
Cupini LM, De Murtas M, Costa C, et al. Obsessive−compulsive disorder and migraine with medication-overuse headache. Headache 2009; 49: 1005-1013.
Silberstein S, Tfelt-Hansen P, Dodick DW, et al. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia 2008; 28: 484-495.
Radat F, Swendsen J. Psychiatric comorbidity in migraine: a review. Cephalalgia 2005; 25: 165-178.
Pascual J, Cola′s R, Castillo J. Epidemiology of chronic daily headache. Curr Pain Headache Rep 2001; 5: 529-536.
Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. Second Edition. Cephalalgia 2004; 24(Suppl. 1): 8-160.
Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 2003; 60: 1308-1312.
Grabe HJ, Meyer C, Hapke U, et al. Lifetime-comorbidity of obsessive-compulsive disorder and subclinical obsessive-compulsive disorder in northern Germany. Eur Arch Psychiatry Clin Neurosci 2001; 251: 130-135.
Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF. Migraine, quality of life and depression: a population-based case−control study. Neurology 2000; 55: 629-635.
Lake AE III, Rains JC, Penzien DB, Lipchik GL. Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance. Headache 2005; 45: 493-506.
Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the validity of the Beck Depression Inventory. A review. Psychopathology 1998; 31: 160-168.
Radat F, Creac'h C, Swendsen JD, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 2005; 25: 519-522.
Katsarava Z, Schneeweiss S, Kurth T, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004; 62: 788-790.
Osman A, Kopper BA, Barrios FX, Osman JR, Wade T. The Beck Anxiety Inventory: reexamination of factor structure and psychometric properties. J Clin Psychol 1997; 53: 7-14.
Fumal A, Laureys S, Di Clemente L, et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 2006; 129(Pt 2): 543-550.
Radat F, Lanteri-Minet M. What is the role of dependence-related behavior in medication-overuse headache? Headache 2010; 50: 1597-1611.
Scher AI, Midgette LA, Lipton RB. Risk factors for headache chronification. Headache 2008; 48: 16-25.
Colás R, Muñoz P, Temprano R, Gómez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004; 62: 1338-1342.
Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 2010; 81: 428-432.
Loder E. The approach to the difficult patient. Handb Clin Neurol 2010; 97: 233-238.
Calabresi P, Cupini LM. Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci 2005; 26: 62-68.
Breslau N, Schultz LR, Stewart WF, Lucia VC, Welch KM. Headache and major depression: is the association specific to migraine? Neurology 2000; 54: 308-313.
Chen YC, Tang CH, Ng K, Wang SJ. Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan. J Headache Pain 2012; 13: 311-319.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629-808.
Corbelli I, Caproni S, Eusebi P, Sarchielli P. Drug-dependence behaviour and outcome of medication-overuse headache after treatment. J Headache Pain 2012; 13: 653-660.
Goodman WK, Price LH, Rasmussen SA, et al. The Yale−Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46: 1006-1011.
Blumenfeld AM, Varon SF, Wilcox TK, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia 2011; 31: 301-315.
Amorim P, Lecrubier Y, Weiller E, Hergueta T, Sheehan D. DSM-IH-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI. Eur Psychiatry 1998; 13: 26-34.
2010; 97
2004; 62
2004; 24
1994; 89
2011; 31
2014; 24
2005; 26
2010; 81
2012; 13
2013; 260
1989; 46
2009; 49
2005; 45
2005; 25
1990; 47
2001; 251
2013; 33
2001; 5
1997; 53
2000; 54
2000; 55
2008; 28
2006; 26
2008; 48
2003; 60
2001; 56
2006; 129
1998; 31
2010; 50
1998; 13
e_1_2_8_28_1
e_1_2_8_29_1
e_1_2_8_24_1
e_1_2_8_25_1
e_1_2_8_26_1
e_1_2_8_27_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_22_1
e_1_2_8_23_1
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_37_1
Headache Classification Committee of the International Headache Society (e_1_2_8_12_1) 2004; 24
e_1_2_8_32_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_33_1
e_1_2_8_30_1
References_xml – reference: Radat F, Creac'h C, Guegan-Massardier E, et al. Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria. Headache 2008; 48: 1026-1036.
– reference: Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 2010; 81: 428-432.
– reference: Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch Gen Psychiatry 1990; 47: 849-853.
– reference: Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629-808.
– reference: Goodman WK, Price LH, Rasmussen SA, et al. The Yale−Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46: 1006-1011.
– reference: Chen YC, Tang CH, Ng K, Wang SJ. Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan. J Headache Pain 2012; 13: 311-319.
– reference: Radat F, Lanteri-Minet M. What is the role of dependence-related behavior in medication-overuse headache? Headache 2010; 50: 1597-1611.
– reference: Radat F, Swendsen J. Psychiatric comorbidity in migraine: a review. Cephalalgia 2005; 25: 165-178.
– reference: Scher AI, Midgette LA, Lipton RB. Risk factors for headache chronification. Headache 2008; 48: 16-25.
– reference: Grabe HJ, Meyer C, Hapke U, et al. Lifetime-comorbidity of obsessive-compulsive disorder and subclinical obsessive-compulsive disorder in northern Germany. Eur Arch Psychiatry Clin Neurosci 2001; 251: 130-135.
– reference: Raistrick D, Bradshaw J, Tober G, Weiner J, Allison J, Healey C. Development of the Leeds Dependence Questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package. Addiction 1994; 89: 563-572.
– reference: Ferrari A, Cicero AF, Bertolini A, Leone S, Pasciullo G, Sternieri E. Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ). Cephalalgia 2006; 26: 187-193.
– reference: Silberstein S, Tfelt-Hansen P, Dodick DW, et al. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia 2008; 28: 484-495.
– reference: Fumal A, Laureys S, Di Clemente L, et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 2006; 129(Pt 2): 543-550.
– reference: Radat F, Creac'h C, Swendsen JD, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 2005; 25: 519-522.
– reference: Blumenfeld AM, Varon SF, Wilcox TK, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia 2011; 31: 301-315.
– reference: Colás R, Muñoz P, Temprano R, Gómez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004; 62: 1338-1342.
– reference: Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the validity of the Beck Depression Inventory. A review. Psychopathology 1998; 31: 160-168.
– reference: Corbelli I, Caproni S, Eusebi P, Sarchielli P. Drug-dependence behaviour and outcome of medication-overuse headache after treatment. J Headache Pain 2012; 13: 653-660.
– reference: Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. Second Edition. Cephalalgia 2004; 24(Suppl. 1): 8-160.
– reference: Breslau N, Schultz LR, Stewart WF, Lipton R, Welch KM. Headache types and panic disorder: directionality and specificity. Neurology 2001; 56: 350-354.
– reference: Pascual J, Cola′s R, Castillo J. Epidemiology of chronic daily headache. Curr Pain Headache Rep 2001; 5: 529-536.
– reference: Katsarava Z, Schneeweiss S, Kurth T, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004; 62: 788-790.
– reference: Calabresi P, Cupini LM. Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci 2005; 26: 62-68.
– reference: Sarchielli P, Messina P, Cupini ML, et al. Sodium Valproate in Medication Overuse Headache Treatment: a placebo-controlled randomized trial. Eur Neuropsychopharmacol 2014; 24: 1289-1297.
– reference: Cupini LM, De Murtas M, Costa C, et al. Obsessive−compulsive disorder and migraine with medication-overuse headache. Headache 2009; 49: 1005-1013.
– reference: Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008; 48: 1157-1168.
– reference: Lake AE III, Rains JC, Penzien DB, Lipchik GL. Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance. Headache 2005; 45: 493-506.
– reference: Breslau N, Schultz LR, Stewart WF, Lucia VC, Welch KM. Headache and major depression: is the association specific to migraine? Neurology 2000; 54: 308-313.
– reference: Osman A, Kopper BA, Barrios FX, Osman JR, Wade T. The Beck Anxiety Inventory: reexamination of factor structure and psychometric properties. J Clin Psychol 1997; 53: 7-14.
– reference: Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 2003; 60: 1308-1312.
– reference: Amorim P, Lecrubier Y, Weiller E, Hergueta T, Sheehan D. DSM-IH-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI. Eur Psychiatry 1998; 13: 26-34.
– reference: Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF. Migraine, quality of life and depression: a population-based case−control study. Neurology 2000; 55: 629-635.
– reference: Buse DC, Silberstein SD, Manack AN, Papapetropoulos S, Lipton RB. Psychiatric comorbidities of episodic and chronic migraine. J Neurol 2013; 260: 1960-1969.
– reference: Schulman EA, Peterlin BL, Lake AE III, et al. Defining refractory migraine: results of the RHSIS Survey of American Headache Society members. Headache 2009; 49: 509-518.
– reference: Loder E. The approach to the difficult patient. Handb Clin Neurol 2010; 97: 233-238.
– volume: 47
  start-page: 849
  year: 1990
  end-page: 853
  article-title: Migraine and psychopathology. Results of the Zurich cohort study of young adults
  publication-title: Arch Gen Psychiatry
– volume: 45
  start-page: 493
  year: 2005
  end-page: 506
  article-title: Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance
  publication-title: Headache
– volume: 48
  start-page: 1026
  year: 2008
  end-page: 1036
  article-title: Behavioral dependence in patients with medication overuse headache: a cross‐sectional study in consulting patients using the DSM‐IV criteria
  publication-title: Headache
– volume: 251
  start-page: 130
  year: 2001
  end-page: 135
  article-title: Lifetime‐comorbidity of obsessive‐compulsive disorder and subclinical obsessive‐compulsive disorder in northern Germany
  publication-title: Eur Arch Psychiatry Clin Neurosci
– volume: 33
  start-page: 629
  year: 2013
  end-page: 808
  article-title: The International Classification of Headache Disorders, 3rd edition (beta version)
  publication-title: Cephalalgia
– volume: 24
  start-page: 1289
  year: 2014
  end-page: 1297
  article-title: Sodium Valproate in Medication Overuse Headache Treatment: a placebo‐controlled randomized trial
  publication-title: Eur Neuropsychopharmacol
– volume: 31
  start-page: 160
  year: 1998
  end-page: 168
  article-title: On the validity of the Beck Depression Inventory. A review
  publication-title: Psychopathology
– volume: 49
  start-page: 1005
  year: 2009
  end-page: 1013
  article-title: Obsessive−compulsive disorder and migraine with medication‐overuse headache
  publication-title: Headache
– volume: 13
  start-page: 653
  year: 2012
  end-page: 660
  article-title: Drug‐dependence behaviour and outcome of medication‐overuse headache after treatment
  publication-title: J Headache Pain
– volume: 25
  start-page: 519
  year: 2005
  end-page: 522
  article-title: Psychiatric comorbidity in the evolution from migraine to medication overuse headache
  publication-title: Cephalalgia
– volume: 60
  start-page: 1308
  year: 2003
  end-page: 1312
  article-title: Comorbidity of migraine and depression: investigating potential etiology and prognosis
  publication-title: Neurology
– volume: 48
  start-page: 16
  year: 2008
  end-page: 25
  article-title: Risk factors for headache chronification
  publication-title: Headache
– volume: 24
  start-page: 8
  issue: Suppl. 1
  year: 2004
  end-page: 160
  article-title: The International Classification of Headache Disorders. Second Edition
  publication-title: Cephalalgia
– volume: 26
  start-page: 62
  year: 2005
  end-page: 68
  article-title: Medication‐overuse headache: similarities with drug addiction
  publication-title: Trends Pharmacol Sci
– volume: 53
  start-page: 7
  year: 1997
  end-page: 14
  article-title: The Beck Anxiety Inventory: reexamination of factor structure and psychometric properties
  publication-title: J Clin Psychol
– volume: 129
  start-page: 543
  issue: Pt 2
  year: 2006
  end-page: 550
  article-title: Orbitofrontal cortex involvement in chronic analgesic‐overuse headache evolving from episodic migraine
  publication-title: Brain
– volume: 50
  start-page: 1597
  year: 2010
  end-page: 1611
  article-title: What is the role of dependence‐related behavior in medication‐overuse headache?
  publication-title: Headache
– volume: 81
  start-page: 428
  year: 2010
  end-page: 432
  article-title: Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 46
  start-page: 1006
  year: 1989
  end-page: 1011
  article-title: The Yale−Brown Obsessive Compulsive Scale. I. Development, use, and reliability
  publication-title: Arch Gen Psychiatry
– volume: 89
  start-page: 563
  year: 1994
  end-page: 572
  article-title: Development of the Leeds Dependence Questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package
  publication-title: Addiction
– volume: 62
  start-page: 1338
  year: 2004
  end-page: 1342
  article-title: Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life
  publication-title: Neurology
– volume: 13
  start-page: 26
  year: 1998
  end-page: 34
  article-title: DSM‐IH‐R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI
  publication-title: Eur Psychiatry
– volume: 62
  start-page: 788
  year: 2004
  end-page: 790
  article-title: Incidence and predictors for chronicity of headache in patients with episodic migraine
  publication-title: Neurology
– volume: 31
  start-page: 301
  year: 2011
  end-page: 315
  article-title: Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS)
  publication-title: Cephalalgia
– volume: 13
  start-page: 311
  year: 2012
  end-page: 319
  article-title: Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan
  publication-title: J Headache Pain
– volume: 48
  start-page: 1157
  year: 2008
  end-page: 1168
  article-title: Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population‐based study
  publication-title: Headache
– volume: 97
  start-page: 233
  year: 2010
  end-page: 238
  article-title: The approach to the difficult patient
  publication-title: Handb Clin Neurol
– volume: 54
  start-page: 308
  year: 2000
  end-page: 313
  article-title: Headache and major depression: is the association specific to migraine?
  publication-title: Neurology
– volume: 55
  start-page: 629
  year: 2000
  end-page: 635
  article-title: Migraine, quality of life and depression: a population‐based case−control study
  publication-title: Neurology
– volume: 56
  start-page: 350
  year: 2001
  end-page: 354
  article-title: Headache types and panic disorder: directionality and specificity
  publication-title: Neurology
– volume: 28
  start-page: 484
  year: 2008
  end-page: 495
  article-title: Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults
  publication-title: Cephalalgia
– volume: 260
  start-page: 1960
  year: 2013
  end-page: 1969
  article-title: Psychiatric comorbidities of episodic and chronic migraine
  publication-title: J Neurol
– volume: 5
  start-page: 529
  year: 2001
  end-page: 536
  article-title: Epidemiology of chronic daily headache
  publication-title: Curr Pain Headache Rep
– volume: 25
  start-page: 165
  year: 2005
  end-page: 178
  article-title: Psychiatric comorbidity in migraine: a review
  publication-title: Cephalalgia
– volume: 49
  start-page: 509
  year: 2009
  end-page: 518
  article-title: Defining refractory migraine: results of the RHSIS Survey of American Headache Society members
  publication-title: Headache
– volume: 26
  start-page: 187
  year: 2006
  end-page: 193
  article-title: Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ)
  publication-title: Cephalalgia
– ident: e_1_2_8_7_1
  doi: 10.1111/j.1526-4610.2010.01755.x
– ident: e_1_2_8_15_1
  doi: 10.1016/S0924-9338(97)86748-X
– ident: e_1_2_8_36_1
  doi: 10.1111/j.1526-4610.2007.00999.x
– ident: e_1_2_8_35_1
  doi: 10.1007/s10194-012-0492-z
– ident: e_1_2_8_13_1
  doi: 10.1159/000066239
– ident: e_1_2_8_25_1
  doi: 10.1016/j.tips.2004.12.008
– ident: e_1_2_8_2_1
  doi: 10.1177/0333102413485658
– ident: e_1_2_8_24_1
  doi: 10.1212/WNL.56.3.350
– ident: e_1_2_8_23_1
  doi: 10.1212/01.WNL.0000058907.41080.54
– ident: e_1_2_8_21_1
  doi: 10.1111/j.1526-4610.2007.00970.x
– ident: e_1_2_8_17_1
  doi: 10.1111/j.1360-0443.1994.tb03332.x
– ident: e_1_2_8_5_1
  doi: 10.1111/j.1468-2982.2005.00910.x
– ident: e_1_2_8_8_1
  doi: 10.1111/j.1526-4610.2005.05101.x
– ident: e_1_2_8_9_1
  doi: 10.1007/s00415-012-6725-x
– ident: e_1_2_8_11_1
  doi: 10.1111/j.1468-2982.2008.01555.x
– volume: 24
  start-page: 8
  issue: 1
  year: 2004
  ident: e_1_2_8_12_1
  article-title: The International Classification of Headache Disorders. Second Edition
  publication-title: Cephalalgia
– ident: e_1_2_8_4_1
  doi: 10.1007/s11916-001-0070-6
– ident: e_1_2_8_31_1
  doi: 10.1177/0333102410381145
– ident: e_1_2_8_27_1
  doi: 10.1001/archpsyc.1990.01810210057008
– ident: e_1_2_8_30_1
  doi: 10.1136/jnnp.2009.192492
– ident: e_1_2_8_19_1
  doi: 10.1212/01.WNL.0000113747.18760.D2
– ident: e_1_2_8_22_1
  doi: 10.1111/j.1468-2982.2004.00839.x
– ident: e_1_2_8_18_1
  doi: 10.1111/j.1468-2982.2005.01020.x
– ident: e_1_2_8_34_1
  doi: 10.1016/S0072-9752(10)97018-8
– ident: e_1_2_8_29_1
  doi: 10.1212/WNL.55.5.629
– ident: e_1_2_8_6_1
  doi: 10.1111/j.1526-4610.2009.01457.x
– ident: e_1_2_8_10_1
  doi: 10.1016/j.euroneuro.2014.03.010
– ident: e_1_2_8_33_1
  doi: 10.1111/j.1526-4610.2009.01370.x
– ident: e_1_2_8_3_1
  doi: 10.1212/01.WNL.0000120545.45443.93
– ident: e_1_2_8_26_1
  doi: 10.1093/brain/awh691
– ident: e_1_2_8_28_1
  doi: 10.1212/WNL.54.2.308
– ident: e_1_2_8_16_1
  doi: 10.1001/archpsyc.1989.01810110048007
– ident: e_1_2_8_32_1
  doi: 10.1007/s10194-012-0447-4
– ident: e_1_2_8_37_1
  doi: 10.1007/s004060170047
– ident: e_1_2_8_14_1
  doi: 10.1002/(SICI)1097-4679(199701)53:1<7::AID-JCLP2>3.0.CO;2-S
– ident: e_1_2_8_20_1
  doi: 10.1111/j.1526-4610.2008.01217.x
SSID ssj0002720
Score 2.3481855
Snippet Background and purpose In medication‐overuse headache (MOH) patients, the presence of psychopathological disturbances may be a predictor of relapse and poor...
In medication-overuse headache (MOH) patients, the presence of psychopathological disturbances may be a predictor of relapse and poor response to treatment....
Background and purpose In medication-overuse headache (MOH) patients, the presence of psychopathological disturbances may be a predictor of relapse and poor...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 85
SubjectTerms Adult
case-control studies
Comorbidity
Female
headache
Headache Disorders, Secondary - epidemiology
Humans
Male
medication-overuse headache
Mental Disorders - epidemiology
Middle Aged
migraine
Migraine Disorders - epidemiology
obsessive−compulsive disturbances
Prevalence
psychiatric disorders
Title Psychopathological comorbidities in medication-overuse headache: a multicentre clinical study
URI https://api.istex.fr/ark:/67375/WNG-C7QWJ7NW-M/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fene.12794
https://www.ncbi.nlm.nih.gov/pubmed/26228376
https://www.proquest.com/docview/1760859772
https://www.proquest.com/docview/1776657418
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxsxEB5MAqGXNk0fcZsWJZTSy5q1Viut01MxToIhhpYG51AQ0lqC4LAufkDpqT-hvzG_JDPaR-vihBL2InZnH5JmRp92Rp8A3iWZUz41KooTn0RCeh-Z1MeRyp33megRzRRlW4zk2YUYXqaXLfhYr4Up-SGaH25kGcFfk4Ebu_jLyNEVdLoc1Qn9L-VqESD68oc6iuKLYbKVdiPSu4pViLJ4mjvXxqJtatYfm4DmOm4NA8_JE_hWf3KZbzLtrJa2k__8h83xgXXahccVIGWfSg16Ci1X7MHOeRVyfwa6dJG0c3HtJxk-dja3V5PAxsquChYi9KGPb379pqTQ1cIxdPMToos-ZoaFvMWQCOpYvRiTBWrb53BxMvjaP4uqXRmiHMGGiHoICmLhnVXYlVy4nvd43k7y1AjrDM4_rBF4FQ9En9xlvOe5c9yLNPYC0dsL2CpmhdsHJkWeTKzMY4-DpOA2k1iWSeKzlCOM5W34UPePzivKcto541rXUxdsMB0arA1Hjej3kqdjk9D70MmNhJlPKbFNpXo8OtV99Xk8VKOxPm_DYa0FGs2NYiimcLPVQneVJEo4nJPcJ6MoniW6WRtelirUvJHLwDcksWpBEe7-WD0YDULh1f-LvoZHCOiqX0QHsLWcr9wbBE1L-zZYxy1V7hLi
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RkGgvpRTabqHFRQhxySrrOHa26gWhpctjI4FAywVZcdaWEFW2Wnalqqf-hP7G_pLOOI-WChCqcomSycueGX_jmXwG2IoSq1ycqSCMXBQI6VyQxS4MVG6dS0SXaKao2iKV_XNxeBFfzMGn-l-Ykh-imXAjy_D-mgycJqT_snL0Be0OR316Agu0orcPqE7_kEdRhtGHW3EnIM2reIWojqe59NZotEAN--0uqHkbufqhZ38JLuuXLitOrtuzqWnn3__hc_zfr3oBzytMynZLJVqGOVu8hMVBlXVfAV16SVq8uHaVDO87npirkSdkZVcF80l6382_fvykutDZjWXo6UfEGP2RZcyXLvpaUMvq_zGZZ7ddhfP93tleP6gWZghyxBsi6CIuCIWzRmFvcmG7zuFxM8rjTBibYQhiMoFncUMAym3Cu45by52IQycQwL2C-WJc2DfApMijkZF56HCcFNwkEvdlFLkk5ohkeQt26g7SecVaTotnfNF19IINpn2DtWCzEf1aUnXcJbTte7mRyCbXVNumYj1MP-s9dTI8VOlQD1rwoVYDjRZHaZSssOPZje4oSaxwGJY8JKMopSU6SQtelzrUPJFLTzkk8dO8Jtz_srqX9vzO28eLbsDT_tngWB8fpEdr8AzxXTVjtA7z08nMvkMMNTXvvan8Bm3gFv0
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fTxQxEJ8gJMQXRVQ4EazGGF_2stfttnvyROBORNmokRwPJM12t00IZo8cdwnhiY_AZ-STMNP9oxg0xOxLszv7p-3M9Ned6a8Ab6PEKhdnKggjFwVCOhdksQsDlVvnEtEnminKtkjl7oHYO4wP52CzWQtT8UO0P9zIMry_JgM_LdxvRo6uoNvjqE4PYEHIMCGV3vn-izuKAox-thX3AlK8mlaI0njaW28NRgvUrud3Ic3bwNWPPMPHcNR8c5VwctKdTU03v_iDzvE_K7UEj2pEyrYqFXoCc7ZchsX9Oub-FHTlI2nr4sZRMnzseGKOC0_Hyo5L5kP0vpOvL68oK3R2Zhn6-YL4oj-wjPnERZ8JalmzGpN5bttncDAc_NjeDeptGYIc0YYI-ogKQuGsUdiXXNi-c3jeFHmcCWMznICYTOBVPBB-cpvwvuPWcifi0AmEb89hvhyXdhWYFHlUGJmHDkdJwU0isSyjyCUxRxzLO_C-6R-d15zltHXGT93MXbDBtG-wDrxpRU8roo67hN75Tm4lsskJZbapWI_Sj3pbfRvtqXSk9zvwutECjfZGQZSstOPZme4pSZxwOCn5l4yigJboJR1YqVSofSOXnnBIYtW8Ivz9Y_UgHfjCi_uLvoLFrztD_eVT-nkNHiK4q38XvYT56WRm1xFATc2GN5QbOgwVtQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Psychopathological+comorbidities+in+medication%E2%80%90overuse+headache%3A+a+multicentre+clinical+study&rft.jtitle=European+journal+of+neurology&rft.au=Sarchielli%2C+P.&rft.au=Corbelli%2C+I.&rft.au=Messina%2C+P.&rft.au=Cupini%2C+L.+M.&rft.date=2016-01-01&rft.issn=1351-5101&rft.eissn=1468-1331&rft.volume=23&rft.issue=1&rft.spage=85&rft.epage=91&rft_id=info:doi/10.1111%2Fene.12794&rft.externalDBID=10.1111%252Fene.12794&rft.externalDocID=ENE12794
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1351-5101&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1351-5101&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1351-5101&client=summon